Enlivex Ltd.ENLV

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$0.61
Market cap
$9.6M
P/E
0.0x
Revenue (FY)
—
Net income
$1.2B
Dividend yield
—
1-year total return
-96.1%
Net margin
—
Revenue growth
—
Debt / equity
—

What Enlivex Ltd. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$11.8M-$14.5M-$31.1M-$29.1M-$15.0M$1.2B
Free cash flow-$12.0M-$19.2M-$32.1M-$23.8M-$13.1M-$10.5M

More on ENLV.

Figures from Enlivex Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.